STERIS plc STE
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
STERIS plc (STE) Return on invested capital
STERIS plc's return on invested capital over the twelve months to 30 June 2026 was 8.27%, up 0.3 percentage points from fiscal 2026 (7.92%). Over the past ten years it has ranged from 3.05% (fiscal 2016) to 9.30% (fiscal 2015); the current reading is higher than 92% of that period. That is above the Medical Devices industry median of −10.3% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | 7.92% | 1.54 |
| FY2025 | 6.38% | 0.77 |
| FY2024 | 5.61% | 0.09 |
| FY2023 | 5.52% | 2.30 |
| FY2022 | 3.22% | (3.19) |
| FY2021 | 6.41% | (1.45) |
| FY2020 | 7.86% | 1.67 |
| FY2019 | 6.19% | 0.42 |
| FY2018 | 5.77% | 2.24 |
| FY2017 | 3.53% | 0.48 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| DXCM DexCom, Inc. compare | 37.1% |
| PEN Penumbra, Inc. compare | 13.1% |
| GEHC GE HealthCare Technologies Inc. compare | 8.37% |
| STE STERIS plc | 8.27% |
| PHG Koninklijke Philips N.V. compare | 6.69% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.82% |
| BIO Bio-Rad Laboratories, Inc. compare | 0.49% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.49% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −10.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement